Cargando…
Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
BACKGROUND: Tumor orchestrated metabolic changes in the microenvironment limit generation of anti-tumor immune responses. Availability of arginine, a semi-essential amino acid, is critical for lymphocyte proliferation and function. Levels of arginine are regulated by the enzymes arginase 1,2 and nit...
Autores principales: | Miret, Juan J., Kirschmeier, Paul, Koyama, Shohei, Zhu, Mingrui, Li, Yvonne Y., Naito, Yujiro, Wu, Min, Malladi, Venkat S., Huang, Wei, Walker, William, Palakurthi, Sangeetha, Dranoff, Glenn, Hammerman, Peter S., Pecot, Chad V., Wong, Kwok-Kin, Akbay, Esra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366094/ https://www.ncbi.nlm.nih.gov/pubmed/30728077 http://dx.doi.org/10.1186/s40425-019-0504-5 |
Ejemplares similares
-
The impact of the MYB-NFIB fusion proto-oncogene in vivo
por: Mikse, Oliver R., et al.
Publicado: (2016) -
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
por: Koyama, Shohei, et al.
Publicado: (2016) -
Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
por: Osa, Akio, et al.
Publicado: (2018) -
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
por: Zhang, Haikuo, et al.
Publicado: (2017) -
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
por: Zhang, Haikuo, et al.
Publicado: (2017)